130 related articles for article (PubMed ID: 3020566)
1. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes.
Pasternak RD; Hubbs SJ; Caccese RG; Marks RL; Conaty JM; DiPasquale G
Clin Immunol Immunopathol; 1986 Dec; 41(3):351-67. PubMed ID: 3536222
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 induces chondrocyte protease production: the development of collagenase inhibitors.
Pasternak RD; Hubbs SJ; Caccese RG; Marks RL; Conaty JM; DiPasquale G
Agents Actions; 1987 Aug; 21(3-4):328-30. PubMed ID: 2825481
[TBL] [Abstract][Full Text] [Related]
4. Lack of response of rat chondrosarcoma chondrocytes to interleukin-1 to produce proteoglycan- and collagen-degrading enzymes.
DiPasquale G; Caccese R; Pasternak R; Caputo CB; Conaty J; Hubbs S
Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):333-9. PubMed ID: 3526479
[TBL] [Abstract][Full Text] [Related]
5. Degradation of cartilage collagens type II, IX, X and XI by enzymes derived from human articular chondrocytes.
Gadher SJ; Eyre DR; Wotton SF; Schmid TM; Woolley DE
Matrix; 1990 Jul; 10(3):154-63. PubMed ID: 2170828
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
7. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
[TBL] [Abstract][Full Text] [Related]
8. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
Nixon JS; Bottomley KM; Broadhurst MJ; Brown PA; Johnson WH; Lawton G; Marley J; Sedgwick AD; Wilkinson SE
Int J Tissue React; 1991; 13(5):237-41. PubMed ID: 1666894
[TBL] [Abstract][Full Text] [Related]
9. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
Shinmei M; Kikuchi T; Masuda K; Shimomura Y
Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes.
Kandel RA; Petelycky M; Dinarello CA; Minden M; Pritzker KP; Cruz TF
J Rheumatol; 1990 Jul; 17(7):953-7. PubMed ID: 2170644
[TBL] [Abstract][Full Text] [Related]
12. Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.
Gowen M; Wood DD; Ihrie EJ; Meats JE; Russell RG
Biochim Biophys Acta; 1984 Feb; 797(2):186-93. PubMed ID: 6320902
[TBL] [Abstract][Full Text] [Related]
13. The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. II. Articular cartilage.
Murphy G; Cambray GJ; Virani N; Page-Thomas DP; Reynolds JJ
Rheumatol Int; 1981; 1(1):17-20. PubMed ID: 6287558
[TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.
Andrews HJ; Plumpton TA; Harper GP; Cawston TE
Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176
[TBL] [Abstract][Full Text] [Related]
15. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
Kozaci LD; Buttle DJ; Hollander AP
Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes.
Murphy G; Hembry RM; Reynolds JJ
Coll Relat Res; 1986 Oct; 6(4):351-63. PubMed ID: 3028709
[TBL] [Abstract][Full Text] [Related]
17. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
Flannery CR; Little CB; Caterson B; Hughes CE
Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
[TBL] [Abstract][Full Text] [Related]
18. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
Steinmeyer J; Daufeldt S; Kalbhen DA
Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
Ganu V; Melton R; Wang W; Roberts D
Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
[No Abstract] [Full Text] [Related]
20. Proteoglycan degradation by a chondrocyte metalloprotease. Effects of synthetic protease inhibitors.
Caputo CB; Wolanin DJ; Roberts RA; Sygowski LA; Patton SP; Caccese RG; Shaw A; DiPasquale G
Biochem Pharmacol; 1987 Apr; 36(7):995-1002. PubMed ID: 3551961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
